Tezepelumab is under investigation in clinical trial NCT03406078 (Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in A’dults With Oral Corticosteroid Dependent Asthma).
货号（Catalog No.）
CSD00406
通用名INN
Tezepelumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Tezepelumab is under investigation in clinical trial NCT03406078 (Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in A’dults With Oral Corticosteroid Dependent Asthma).
别名(Alternative names)
AMG 157,AMG-157,MEDI-9929,MEDI9929,anti-TSLP-Receptor (TSLP-R; Crl2)
靶点;物种(Specificity target name;species)
TSLP[Homo sapiens]
种类(Species)
Homo sapiens
受体鉴定(Receptor identification)
IgG2-lambda
化学信息
CAS
1572943-04-4
存储条件(Storage)
store at -80°C